Companies Dominating the Psychedelic Drugs Landscape
- Compass Pathways Plc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mind Medicine Inc.
- Jazz Pharmaceuticals plc
- Johnson & Johnson Pte. Ltd.
- Hikma Pharmaceuticals PLC
- Thoughtful Brands Inc.
- Pfizer Inc.
- F. Hoffmann-La Roche AG
- Avadel Pharmaceuticals plc
- NRx Pharmaceuricals, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Psychedelic Drugs Market in 2025 is assessed at USD 21.9 billion.
The global market size was valued at around USD 19.84 billion in 2024 and is projected to grow at a CAGR of more than 13%, reaching USD 97.18 billion revenue by 2037.
North America is poised to collect USD 38.87 billion by 2037, due to rising government initiatives to raise awareness about mental health conditions.
The major players in the market include Compass Pathways Plc., Mind Medicine Inc., Jazz Pharmaceuticals plc, Johnson & Johnson Pte. Ltd., Hikma Pharmaceuticals PLC, Thoughtful Brands Inc., Pfizer Inc., F. Hoffmann-La Roche AG, Avadel Pharmaceuticals plc, NRx Pharmaceuricals, Inc.
